Hypermethylated PCDHGB7 as a universal cancer only marker and its application in early cervical cancer screening

• Shihua Dong,
• Qi Lu,
• Peng Xu,
• Limei Chen,
• Xiaoling Duan,
• Zhanrui Mao,
• Baolong Zhang,
• Long Sui,
• Yudong Wang,
• Wenqiang Yu

Affiliations

Shihua Dong

Research and Development Department Shanghai Epiprobe Bio‐Technology Co., Ltd Shanghai China

Qi Lu

Department of Obstetrics and Gynecology Jinshan Hospital of Fudan University Shanghai China

Peng Xu

Shanghai Public Health Clinical Center Department of General Surgery, Huashan Hospital Cancer Metastasis Institute Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences Shanghai Medical College, Fudan University Shanghai China

Limei Chen

Medical Center for Diagnosis and Treatment of Cervical Disease, Obstetrics and Gynecology Hospital, Fudan University Shanghai Key Laboratory of Female Reproductive Endocrine‐Related Diseases Shanghai China

Xiaoling Duan

Department of Obstetrics and Gynecology Jinshan Hospital of Fudan University Shanghai China

Zhanrui Mao

Research and Development Department Shanghai Epiprobe Bio‐Technology Co., Ltd Shanghai China

Baolong Zhang

Shanghai Public Health Clinical Center Department of General Surgery, Huashan Hospital Cancer Metastasis Institute Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences Shanghai Medical College, Fudan University Shanghai China

Long Sui

Medical Center for Diagnosis and Treatment of Cervical Disease, Obstetrics and Gynecology Hospital, Fudan University Shanghai Key Laboratory of Female Reproductive Endocrine‐Related Diseases Shanghai China

Yudong Wang

Department of Gynecology, International Peace Maternity and Child Health Hospital Shanghai Jiaotong University School of Medicine Shanghai China

Wenqiang Yu

Shanghai Public Health Clinical Center Department of General Surgery, Huashan Hospital Cancer Metastasis Institute Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences Shanghai Medical College, Fudan University Shanghai China